Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

21.70
Delayed Data
As of 2:58pm ET
 +0.185 / +0.86%
Today’s Change
15.25
Today|||52-Week Range
24.20
+35.00%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close21.51
Today’s open21.55
Day’s range21.55 - 21.76
Volume373,721
Average volume (3 months)592,450
Market cap$5.5B
Data as of 2:58pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+3.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.40%
Revenue growth (last year)+2.94%
P/E ratio22.5
Price/Sales2.46
Price/Book3.74

Competitors

----
RDYDr.Reddy's Laborator...+0.70+1.92%
CTLTCatalent Inc+1.05+2.62%
UTHRUnited Therapeutics ...+1.64+1.21%
Data as of 3:13pm ET, 12/15/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)$0.30
Annual revenue (last year)$4.5B
Annual profit (last year)$602.1M
Net profit margin13.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Executive Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts